FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WHITE MILES D
2. Issuer Name and Ticker or Trading Symbol

ABBOTT LABORATORIES [ ABT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman and CEO
(Last)          (First)          (Middle)

100 ABBOTT PARK ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

12/6/2017
(Street)

ABBOTT PARK, IL 60064-6400
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common shares without par value   12/6/2017     S    4702   D $54.76   3225385   D    
Common shares without par value   12/6/2017     S    398   D $54.765   3224987   D    
Common shares without par value   12/6/2017     S    4439   D $54.77   3220548   D    
Common shares without par value   12/6/2017     S    1097   D $54.775   3219451   D    
Common shares without par value   12/6/2017     S    3898   D $54.78   3215553   D    
Common shares without par value   12/6/2017     S    1400   D $54.785   3214153   D    
Common shares without par value   12/6/2017     S    2300   D $54.79   3211853   D    
Common shares without par value   12/6/2017     S    1200   D $54.795   3210653   D    
Common shares without par value   12/6/2017     S    5600   D $54.80   3205053   D    
Common shares without par value   12/6/2017     S    398   D $54.805   3204655   D    
Common shares without par value   12/6/2017     S    6200   D $54.81   3198455   D    
Common shares without par value   12/6/2017     S    1602   D $54.815   3196853   D    
Common shares without par value   12/6/2017     S    4500   D $54.82   3192353   D    
Common shares without par value   12/6/2017     S    200   D $54.825   3192153   D    
Common shares without par value   12/6/2017     S    2403   D $54.83   3189750   D    
Common shares without par value   12/6/2017     S    1000   D $54.835   3188750   D    
Common shares without par value   12/6/2017     S    4297   D $54.84   3184453   D    
Common shares without par value   12/6/2017     S    2359   D $54.845   3182094   D    
Common shares without par value   12/6/2017     S    6975   D $54.85   3175119   D    
Common shares without par value   12/6/2017     S    144   D $54.855   3174975   D    
Common shares without par value   12/6/2017     S    2500   D $54.86   3172475   D    
Common shares without par value   12/6/2017     S    197   D $54.865   3172278   D    
Common shares without par value   12/6/2017     S    3897   D $54.87   3168381   D    
Common shares without par value   12/6/2017     S    100   D $54.875   3168281   D    
Common shares without par value   12/6/2017     S    3103   D $54.88   3165178   D    
Common shares without par value   12/6/2017     S    1500   D $54.89   3163678   D    
Common shares without par value   12/6/2017     S    499   D $54.895   3163179   D    
Common shares without par value   12/6/2017     S    1618   D $54.90   3161561   D    
Common shares without par value   12/6/2017     S    797   D $54.905   3160764   D    
Common shares without par value   12/6/2017     S    2207   D $54.91   3158557   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 4 of 5.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WHITE MILES D
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-6400
X
Chairman and CEO

Signatures
John A. Berry, by power of attorney for Miles D. White 12/8/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.